Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/17/26 19:15 | 2/17/26 | TNYA | Health | BioPrd | Biological Products, (No Diag | Higa Tomohiro | CA | O | SVP,Fina | 5 | S | -10 | 0.8321 | 0 | -12 | 120 | D | |||||||||||||||
2/17/26 19:14 | 8/18/25 | TNYA | Health | BioPrd | Biological Products, (No Diag | Ali Faraz | CA | DO | CEO | 5 | S | -39 | 0.8489 | 0 | -45 | 443 | D | |||||||||||||||
2/17/26 19:13 | 8/18/25 | TNYA | Health | BioPrd | Biological Products, (No Diag | Tingley Whittemore | CA | O | Chief Me | 5 | S | -19 | 0.8008 | 0 | -23 | 219 | D | |||||||||||||||
2/12/26 17:19 | 2/10/26 | TNYA | Health | BioPrd | Biological Products, (No Diag | Column Group III Gp, LP | CA | T | 1 | S.m | -3,042 | 0.6914 | 0 | -4,400 | 51,965 | I | ||||||||||||||||
11/18/24 20:48 | 11/18/24 | TNYA | Health | BioPrd | Biological Products, (No Diag | Saito Chihiro | CA | O | SVP,Acco | 1 | S | -5 | 2.12 | 0 | -2 | 61 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |